Johannes Keltjens

Johannes Keltjens

Chairman at Sapiens Steering Brain Stimulation BV

67 year
Health Technology
Electronic Technology
Consumer Services

Profile

Johannes C.
M.
Keltjens
currently works at JenaValve Technology GmbH, as Executive Chairman, JenaValve Technology, Inc., as Chairman, Sapiens Steering Brain Stimulation BV, as Chairman & President from 2014, and ViCentra BV, as Chairman from 2017.
Mr. Keltjens also formerly worked at CryoCath Technologies, Inc., as President & Chief Executive Officer from 2007 to 2009, AngioDynamics, Inc., as President, Chief Executive Officer & Director from 2009 to 2011, ENDOSENSE SA, as President & Chief Executive Officer from 2011 to 2012, Surpass Medical Ltd., as Executive Chairman, and Cordis Neurovascular, Inc., as General Manager in 2007.
Mr. Keltjens received his graduate degree from Technische Universiteit Eindhoven.

Johannes Keltjens active positions

CompaniesPositionStart
Chairman 2013-10-20
Chairman 2015-01-27
Chairman -
Chairman 2017-03-06
All active positions of Johannes Keltjens

Former positions of Johannes Keltjens

CompaniesPositionEnd
ANGIODYNAMICS, INC. Chief Executive Officer 2011-06-07
Chief Executive Officer 2009-01-31
Cordis Neurovascular, Inc. Corporate Officer/Principal 2006-12-31
Chairman -
Chief Executive Officer -
See the detail of Johannes Keltjens's experience

Training of Johannes Keltjens

Technische Universiteit Eindhoven Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Johannes Keltjens's experience

Connections

64

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ANGIODYNAMICS, INC.

Health Technology

Private companies8

Health Technology

Cordis Neurovascular, Inc.

Health Technology

Electronic Technology

Electronic Technology

Health Technology

Health Technology

Electronic Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Johannes Keltjens
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW